Retinol binding protein as early marker of fetal growth restriction in first trimester maternal serum

Gynecological Endocrinology

Volumn 29, Issue 4, 2013, Pages 323-326

  Fruscalzo, Arrigo ^a   Biasioli, Anna ^b,c   Londero, Ambrogio P ^c   Ceraudo, Maria ^c   Stel, Giuliana ^c   Bertozzi, Serena ^c   Marchesoni, Diego ^c   Driul, Lorenza ^c   Curcio, Francesco ^c  

^a ST FRANZISKUS HOSPITAL   (Germany)

^b S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Fetal growth restriction; Pregnancy; Retinol binding protein

Indexed keywords

BIOCHEMICAL MARKER; PREALBUMIN; RETINOL BINDING PROTEIN 4; THYROXINE; BIOLOGICAL MARKER; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CAUCASIAN; CLINICAL ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL AGE; MATERNAL SERUM; PREECLAMPSIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BLOOD; PREGNANCY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RETINOL-BINDING PROTEINS, PLASMA; RETROSPECTIVE STUDIES;

EID: 84883201194     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.743013     Document Type: Article

References (23)

1. Hui L, Challis D. Diagnosis and management of fetal growth restriction: the role of fetal therapy. Best Pract Res Clin Obstet Gynaecol 2008;22:139-58.
2. Bernstein PS, Divon MY. Etiologies of fetal growth restriction. Clin Obstet Gynecol 1997;40:723-9.
3. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008;51:970-5.
4. Fruscalzo A, Bertozzi S, Londero AP, et al. Menstrual abnormalities and predisposition to pregnancy-related hypertensive disorders: a retrospective study. Gynecol Endocrinol 2010;26:445-50.
5. Gaetani S, Bellovino D, Apreda M, Devirgiliis C. Hepatic synthesis, maturation and complex formation between retinol-binding protein and transthyretin. Clin Chem Lab Med 2002;40:1211-20.
6. Johansson S, Gustafson AL, Donovan M, et al. Retinoid binding proteins-expression patterns in the human placenta. Placenta 1999;20:459-65.
7. Robbins J. Transthyretin from discovery to now. Clin Chem Lab Med 2002;40:1183-90.
8. Zanotti G, Berni R. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin. Vitam Horm 2004;69:271-95.
9. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-62.
10. Wolf G. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutr Rev 2007;65:251-6.
11. Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.
12. Chauhan SP, Gupta LM, Hendrix NW, Berghella V. Intrauterine growth restriction: comparison of American College of Obstetricians and Gynecologists practice bulletin with other national guidelines. Am J Obstet Gynecol 2009;200:409 e1-6.
13. Nesterenko TH, Aly H. Fetal and neonatal programming: evidence and clinical implications. Am J Perinatol 2009;26:191-8.
14. Kajantie E, Eriksson JG, Osmond C, et al. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009;40:1176-80.
15. Brodsky D, Christou H. Current concepts in intrauterine growth restriction. J Intensive Care Med 2004;19:307-19.
16. Mazaki-Tovi S, Romero R, Vaisbuch E, et al. Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus. J Perinat Med 2010;38:147-55.
17. Laudes M, Oberhauser F, Bilkovski R, et al. Human fetal adiponectin and retinol-binding protein (RBP)-4 levels in relation to birth weight and maternal obesity. Exp Clin Endocrinol Diabetes 2009;117:146-9.
18. Vaisbuch E, Romero R, Mazaki-Tovi S, et al. Retinol binding protein 4-a novel association with early-onset preeclampsia. J Perinat Med 2010;38:129-39.
19. Shangguan X, Liu F, Wang H, et al. Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia. Clin Chim Acta 2009;407:58-61.
20. Inoue S, Takamoto N, Akahori Y, et al. Elevated level of serum retinol-binding protein 4 in pregnancy-induced hypertension. J Obstet Gynaecol Res 2009;35:293-300.
21. Pecks U, Seidenspinner F, Rower C, et al. Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: a strategy to distinguish patients with preeclampsia from matching control individuals. J Am Soc Mass Spectrom 2010;21:1699-711.
22. Vascotto C, Salzano AM, D'Ambrosio C, et al. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res 2007;6:160-70.
23. Raghu P, Sivakumar B. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis. Biochim Biophys Acta 2004;1703:1-9.